WINSTON-SALEM, N.C.--Pilot Therapeutics announced that it has selected its commercial formulation for a dietary supplement for asthma. The new formulation is a patented and clinically optimized mix of dietary fatty acids that provides anti-inflammatory action by blocking the production of leukotrienes. The formulation is a liquid emulsion for mixing in liquids such as water, juice or yogurt or for combining with other liquid nutritional products. The formulation contains only natural orange and peach flavors, colors, preservatives and antioxidants. For more information, call (336) 725-2222.